Evofosfamide sensitizes esophageal carcinomas to radiation without increasing normal tissue toxicity.
Spiegelberg L, van Hoof SJ, Biemans R, Lieuwes NG, Marcus D, Niemans R, Theys J, Yaromina A, Lambin P, Verhaegen F, Dubois LJ.
Spiegelberg L, et al. Among authors: theys j.
Radiother Oncol. 2019 Dec;141:247-255. doi: 10.1016/j.radonc.2019.06.034. Epub 2019 Aug 17.
Radiother Oncol. 2019.
PMID: 31431383
Free PMC article.